- Giuseppe Accogli is a successful executive leader with 25 years of international experience in the Med-tech sector of reputable and complex companies such as Tyco Healthcare (Covidien), Baxter and Medtronic
- “As CEO, I strive to enable our leaders, associates and partners to achieve even greater success in fulfilling the commitment to be an enduring force for good in the biopharmaceutical industry,” said Giuseppe Accogli
PARMA, Italy, January 30, 2023 /PRNewswire/ — Chiesi, the international research-driven biopharmaceutical group, is pleased to announce Giuseppe Accogli as the new CEO of the group. He will join Chiesi from April 3rd 2023, following a thorough and accurate international search.
Giuseppe Accogli is a successful executive leader with 25 years of international experience in the medical technology sector of well-known and complex companies such as Baxter and Medtronic.
He brings a strong background in multiple disciplines (such as sales, marketing, R&D, M&A, strategy and product innovation), with a focus on the US and EMEA markets.
The combination of his experience, his values and his dynamism make him an ideal candidate for the Chiesi group.
“I am honored to lead Chiesi into its new stages of growth and thank the Board of Directors for their trust and the opportunity they offer me to be part of such an exciting journey” Giuseppe Accogli said. “At its core, Chiesi is a group of innovative and highly committed professionals who care about the health and well-being of people around the world, leaving a positive impact on the environment and the communities in which the company operates. As CEO, I strive to enable our leaders, our employees and our partners to achieve even greater success in fulfilling this commitment to be an enduring force for good in the biopharmaceutical industry.”
“We are delighted to have Giuseppe as CEO”, Alberto Chiesi, President of the Chiesi Group, declares. “He is a proven leader with the vision and strength to build on the success that Chiesi has built over the past 85 years and usher us into our next phase of growth and innovation.”
Marco Vechiawho served as interim CEO as well as Head of Global Strategy and Business Development and Head of Legal and Corporate Affairs for the past several months, will continue as Head of Legal and Corporate Affairs.